Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy
NCT04582591
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Chemotherapy-induced Peripheral Neuropathy
Interventions
DRUG:
Cannabidiol 100 MG/ML
Sponsor
Zealand University Hospital
Collaborators
[object Object]